FMR1 and fragile X syndrome: Recent research has shown that metformin reduces this exaggerated synaptic release and Munc18-1 accumulation in the presynaptic terminals of neurons in Fmr1 KO mice (Takeda et al., 2023) and suggests the value of research into the association between LRRTM2 and FXS.